Raskob, G. E., Spyropoulos, A. C., Spiro, T. E., Lu, W., Yuan, Z., Levitan, B., . . . Barnathan, E. S. (2021). Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER. Wiley.
Style de citation Chicago (17e éd.)Raskob, Gary E., Alex C. Spyropoulos, Theodore E. Spiro, Wentao Lu, Zhong Yuan, Bennett Levitan, Eunyoung Suh, et Elliot S. Barnathan. Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER. Wiley, 2021.
Style de citation MLA (8e éd.)Raskob, Gary E., et al. Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER. Wiley, 2021.